Resultados de la búsqueda 201-210 of 1282 for Iron overload

  1. Salud del adulto - Mayo Clinic

    News · enero 2026 · noviembre 2025 · octubre 2025 · septiembre 2025 · agosto 2025 · julio 2025 · mayo 2025 · abril 2025.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine the time from intramuscular injection to the time of first fetal movement after a fetal surgery ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity of on-time and serial administration of MV-s-NAP in patients with metastic breast cancer. Sacituzumab Tirumotecan (MK-2870) In Combination With ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... toxicity of on-time and serial administration of MV-s-NAP in patients with metastic breast cancer. Sacituzumab Tirumotecan (MK-2870) In Combination With ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  9. Presión arterial alta (hipertensión)

    Thomas G, et al. Blood pressure measurement in the diagnosis and treatment of hypertension in adults. https://www.uptodate.com/contents/search. Accessed July 18 ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...